Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 647 across all filing types
Latest filing 2026-03-24 Director's Dealing
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” (Form 6.1), a mandatory regulatory filing disclosing share ownership changes by a director/major shareholder. It details the officer’s acquisition/disposal of equity, loaned shares and resulting holdings. This matches the insider share transaction category (“Director’s Dealing”). Hence, Code DIRS.
2026-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a regulatory report detailing the ownership and changes in shareholdings by an executive/major shareholder (“임원ㆍ주요주주 특정증권등 소유상황보고서”), including dates, share counts before and after transactions, and transaction details. This matches the definition of insider share transaction reporting by directors or executives.
2026-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a statutory ‘대량보유상황보고서’ (Report on Large Holdings of Shares) filed under the Capital Markets Act, detailing the number of shares held, changes in holdings, and related major shareholder disclosures. This corresponds exactly to a Major Shareholding Notification (not a general regulatory announcement or earnings report). Therefore, it falls under category 20: Major Shareholding Notification (Code: MRQ).
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for GemVax & KAEL for the fiscal year ending December 31, 2025. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a comprehensive financial report for a full fiscal year, which falls under the definition of an Annual Report (10-K). FY 2025
2026-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in Korea. This type of filing is a standard regulatory disclosure for insider shareholding changes, which falls under the 'Director's Dealing' category (DIRS) as it reports personal share transactions and ownership status by major shareholders and executives.
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company GemVax. It contains the auditor's opinion (적정 - unqualified), financial statements (consolidated and separate), and key financial metrics for the fiscal year ending 2025-12-31. While it provides financial data, it is specifically the disclosure of the audit results and the auditor's opinion, which falls under the 'Audit Report / Information' category. FY 2025
2026-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.